Key result
Data science, novel diagnostics, and therapies advance rare cardiac disease management, highlighting specialized centers.
Why the study?
Prior interest in rare cardiac conditions was limited by scarce mechanistic data and ineffective management strategies, but recent innovations have emerged.
Recent innovations in data science, diagnostics, and targeted therapies have significantly advanced the understanding and management of rare cardiac diseases.
May support referral to specialized centers for rare cardiac diseases; leaves open prospective validation of data science innovations.
Prior interest in rare cardiac conditions was limited because of a dearth of data on disease mechanisms and pathogenicity in addition to ineffective and uninformed management strategies.However, recent innovations in data science, advanced diagnostics and novel diseasetargeting therapies have thrust rare cardiac diseases into a long-deserving spotlight.In this review, we provide the reader with an overview of rare cardiac diseases, review impactful technological developments and discuss ongoing barriers to care and strategies to mitigate these obstacles.Finally, we discuss the potential role of centres for rare cardiac diseases in enhancing care and foster innovation.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) conducted a review in Rare cardiac diseases. Recent innovations in data science, advanced diagnostics, and novel therapies have advanced the management of rare cardiac diseases, highlighting the potential role of specialized centers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: